IV 112th CONGRESS 1st Session H. RES. 201 IN THE HOUSE OF REPRESENTATIVES April 4, 2011 Mr. Kildee submitted the following resolution; which was referred to the Committee on Energy and Commerce RESOLUTION Expressing support for the designation of May as Ehlers-Danlos Syndrome Awareness Month to increase the knowledge of this little-known, potentially fatal, genetic disease.

Whereas Ehlers-Danlos Syndrome represents multiple genetic disorders involving mutations in connective tissue that are characterized by looseness, instability, and dislocation of the joints and fragile skin that easily bruises and scars; Whereas there are 6 major types of Ehlers-Danlos Syndrome that are characterized by distinctive features, with vascular Ehlers-Danlos Syndrome being the most severe; Whereas it is estimated that the prevalence of all types of the syndrome affect up to 1 in 5,000 people worldwide; Whereas a network of Ehlers-Danlos Syndrome support groups can help connect those managing life with the disease as well as better inform the health care community and the public; Whereas early and accurate diagnosis can provide the opportunity to create lifesaving medical plans and ensure the quality of life; Whereas there is currently no treatment for Ehlers-Danlos Syndrome and no known cure; Whereas further medical research and awareness bring hope for treatment and a cure; and Whereas the month of May would be an appropriate month to designate as Ehlers-Danlos Syndrome Awareness Month: Now, therefore, be it

That the House of Representatives— (1)supports the designation of Ehlers-Danlos Syndrome Awareness Month; (2)honors those bravely suffering from Ehlers-Danlos Syndrome; and (3)encourages scientific research and funding to find a cure for Ehlers-Danlos Syndrome.